Manufactured Object – Page 24

Theratechnologies Warns of Temporary Supply Disruption for EGRIFTA SV in Early 2025 Due to Third-Party Facility Shutdown

12 months ago talkbio0Tagged Disruption, Egrifta, Facility (object), HIV drug, shutdown, sievert, Theratechnologies

Theratechnologies, EGRIFTA SV, supply disruption, third-party facility shutdown, HIV drug, 2025

Cigna’s Express Scripts Files Lawsuit Against FTC Over Allegedly Biased PBM Report

12 months ago talkbio0Tagged Biases, Erroneous, Express, Health care facility, lawsuit, Pharmacy Benefit Manager, Prices, Report (document), United States Federal Trade Commission

Express Scripts, FTC, PBM Report, Lawsuit, Biased, Erroneous, Drug Prices, Healthcare

CDMO Serán Secures $200M Investment from Bain Capital to Establish First Commercial Facility

12 months ago talkbio0Tagged Bain Capital, Biopharmaceutical manufacturing, CDMO, commercial, Facility (object), Investments, Serán

CDMO Serán, Bain Capital, commercial facility, biopharmaceutical manufacturing, investment

Bristol Myers Terminates Partnership with Immatics on Bispecific Cancer Drug After $150M Investment

12 months ago talkbio0Tagged bispecific cancer, Immatics, Investments, Myers, partnership termination, squibb

Bristol Myers Squibb, Immatics, bispecific cancer drug, partnership termination, $150M investment

Bayer Seeks to Broaden Nubeqa’s Use in Prostate Cancer with Chemotherapy-Free Treatment Option

12 months ago talkbio0Tagged Antiandrogen therapy, ARANOTE, Bayer, Chemotherapy-free, Clinical Trials, darolutamide, expansion, Labels (device), Malignant neoplasm of prostate, Metastatic to, mHSPC, Nubeqa

Nubeqa, Bayer, prostate cancer, chemotherapy-free, label expansion, ARANOTE trial, darolutamide, androgen deprivation therapy (ADT), metastatic hormone-sensitive prostate cancer (mHSPC)

Eli Lilly Expands Irish Manufacturing with Additional $1B Investment

1 year ago talkbio0Tagged Biological Factors, Eli, Eli Lilly, expansion, Investments, Ireland, Kinsale, Limerick, Manufacture

Eli Lilly, Ireland, manufacturing expansion, biologics, pharmaceuticals, investment, Limerick, Kinsale

FDA Approves Over-the-Counter Hearing Aid Software for Apple AirPods Pro

1 year ago talkbio0Tagged Approved, Computer software, Genus Malus, Hearing, Hearing Aids, Moderate (severity modifier), United States Food and Drug Administration

FDA approval, over-the-counter hearing aids, Apple AirPods Pro, hearing aid software, mild to moderate hearing loss

Triple Threat: 50% of Women Delay or Skip Medical Care Due to Affordability, Access, and Negative Experiences

1 year ago talkbio0Tagged Access, Affordability, barriers, Delayed medical care, disparities, Experience, Gender, Health care facility, Healthcare equity, issues, Negative, Women 's healthcare

Women’s healthcare, Delayed medical care, Affordability issues, Access barriers, Negative healthcare experiences, Gender disparities in healthcare, Healthcare equity